Kohjin Bio Co., Ltd. (TYO:177A)
Japan · Delayed Price · Currency is JPY 883.00
-15.00 (-1.67%)
Jul 16, 2026, 9:02 AM JST
Kohjin Bio Market Cap
Kohjin Bio has a market cap or net worth of 4.59 billion as of July 15, 2026. Its market cap has decreased by -48.51% in one year.
Market Cap
4.59B
Enterprise Value
4.29B
Revenue
4.94B
Ranking
n/a
PE Ratio
18.29
Stock Price
883.00
Market Cap Chart
Since April 25, 2024, Kohjin Bio's market cap has decreased from 11.89B to 4.59B, a decrease of -61.38%. That is a compound annual growth rate of -34.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 4.59B | -39.69% |
| Dec 30, 2025 | 7.61B | -11.16% |
| Dec 30, 2024 | 8.57B | -27.92% |
| Apr 25, 2024 | 11.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrightPath Biotherapeutics | 6.94B |
| CellSource | 6.89B |
| Noile-Immune Biotech | 5.95B |
| PRISM BioLab Co.,LTD | 5.80B |
| Chiome Bioscience | 5.59B |
| Soiken Holdings | 5.55B |
| TMS Co., Ltd. | 4.74B |
| D. Western Therapeutics Institute | 4.71B |